A second analysis in this cohort separating neuroblastomas harbouring either mutant ALK (ALKmut) or mutations in other RAS/MAPK pathway genes (RAS/MAPK mutwithout ALK) also revealed significant differences compared to wild-type backgrounds (Fig. 1h). The gene discussed is ALK; the disease is neuroblastoma.